Sodium channel mutations and arrhythmias

[1]  S. Sungkanuparph,et al.  A CASE SERIES AND REVIEW OF THE LITERATURE , 2011 .

[2]  S. Priori,et al.  Yield of Genetic Screening in Inherited Cardiac Channelopathies: How to Prioritize Access to Genetic Testing , 2009, Circulation. Arrhythmia and electrophysiology.

[3]  A. Grace,et al.  Correlations between clinical and physiological consequences of the novel mutation R878C in a highly conserved pore residue in the cardiac Na+ channel , 2008, Acta physiologica.

[4]  A. Wilde,et al.  SCN5A overlap syndromes: no end to disease complexity? , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  Keiko Tsuji,et al.  A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[6]  A. Grace,et al.  The cardiac sodium channel mutation delQKP 1507–1509 is associated with the expanding phenotypic spectrum of LQT3, conduction disorder, dilated cardiomyopathy, and high incidence of youth sudden death , 2008, Europace.

[7]  D. Tester,et al.  Syntrophin mutation associated with long QT syndrome through activation of the nNOS–SCN5A macromolecular complex , 2008, Proceedings of the National Academy of Sciences.

[8]  H. Wichmann,et al.  Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. , 2008, The Journal of clinical investigation.

[9]  E. Behr,et al.  The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. , 2008, The Journal of clinical investigation.

[10]  Y. Li,et al.  Molecular and Clinical Characterization of a Novel SCN5A Mutation Associated With Atrioventricular Block and Dilated Cardiomyopathy , 2008, Circulation. Arrhythmia and electrophysiology.

[11]  D. Tester,et al.  A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardia. , 2007, Cardiovascular research.

[12]  P. C. Viswanathan,et al.  Mutation in Glycerol-3-Phosphate Dehydrogenase 1–Like Gene (GPD1-L) Decreases Cardiac Na+ Current and Causes Inherited Arrhythmias , 2007, Circulation.

[13]  G. Filippatos,et al.  Prevalence of paroxysmal atrial fibrillation in Brugada syndrome: a case series and a review of the literature , 2007, Journal of cardiovascular medicine.

[14]  S. Priori,et al.  Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients , 2007, Circulation.

[15]  Michael J Ackerman,et al.  SCN4B-Encoded Sodium Channel &bgr;4 Subunit in Congenital Long-QT Syndrome , 2007, Circulation.

[16]  C. Antzelevitch.  Heterogeneity and cardiac arrhythmias: an overview. , 2007, Heart rhythm.

[17]  Henggui Zhang,et al.  SCN5A and sinoatrial node pacemaker function. , 2007, Cardiovascular research.

[18]  W. Colledge,et al.  Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/− murine hearts modelling the Brugada syndrome , 2007, The Journal of physiology.

[19]  J. Stockman.  Genetic Testing in the Long QT Syndrome: Development and Validation of an Efficient Approach to Genotyping in Clinical Practice , 2007 .

[20]  P. C. Viswanathan,et al.  A sodium channel pore mutation causing Brugada syndrome. , 2007, Heart rhythm.

[21]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[22]  P. Carmeliet,et al.  Overlap Syndrome of Cardiac Sodium Channel Disease in Mice Carrying the Equivalent Mutation of Human SCN5A-1795insD , 2006, Circulation.

[23]  Michael J Ackerman,et al.  Mutant Caveolin-3 Induces Persistent Late Sodium Current and Is Associated With Long-QT Syndrome , 2006, Circulation.

[24]  S. Priori,et al.  Gene-specific therapy for inherited arrhythmogenic diseases. , 2006, Pharmacology & therapeutics.

[25]  A. Moss,et al.  Mutation-specific pharmacology of the long QT syndrome. , 2006, Handbook of experimental pharmacology.

[26]  S. Priori,et al.  Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. , 2005, JAMA.

[27]  Simona Casini,et al.  Sodium channel dysfunction in inherited and acquired cardiac diseases , 2008 .

[28]  N. Makita,et al.  Congenital atrial standstill associated with coinheritance of a novel SCN5A mutation and connexin 40 polymorphisms. , 2005, Heart rhythm.

[29]  A. Grant.  Electrophysiological Basis and Genetics of Brugada Syndrome , 2005, Journal of cardiovascular electrophysiology.

[30]  Alfred L George,et al.  Inherited disorders of voltage-gated sodium channels. , 2005, The Journal of clinical investigation.

[31]  A. Wilde,et al.  A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. , 2005, Journal of molecular and cellular cardiology.

[32]  D. Gros,et al.  Mouse Model of SCN5A-Linked Hereditary Lenègre’s Disease: Age-Related Conduction Slowing and Myocardial Fibrosis , 2005, Circulation.

[33]  A. Kobori,et al.  High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations. , 2005, Journal of the American College of Cardiology.

[34]  Wataru Shimizu,et al.  Brugada syndrome: report of the second consensus conference. , 2005, Heart rhythm.

[35]  R. Kass,et al.  Regulation of the voltage-gated cardiac sodium channel Nav1.5 by interacting proteins. , 2005, Trends in cardiovascular medicine.

[36]  R. Kass,et al.  Inherited and acquired vulnerability to ventricular arrhythmias: cardiac Na+ and K+ channels. , 2005, Physiological reviews.

[37]  Carlo Napolitano,et al.  Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S. Priori,et al.  Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. , 2004, JAMA.

[39]  F. Chiang,et al.  A novel SCN5A mutation manifests as a malignant form of long QT syndrome with perinatal onset of tachycardia/bradycardia. , 2004, Cardiovascular research.

[40]  S. Priori,et al.  Association of Long QT Syndrome Loci and Cardiac Events Among Patients Treated With β-Blockers , 2004 .

[41]  A. Jahangir,et al.  A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs. , 2004, Cardiovascular research.

[42]  S. Priori.  Inherited Arrhythmogenic Diseases: The Complexity Beyond Monogenic Disorders , 2004, Circulation research.

[43]  Lucas J Herfst,et al.  Trafficking and functional expression of cardiac Na+ channels. , 2004, Journal of molecular and cellular cardiology.

[44]  M. Chung,et al.  Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo. , 2004, Cardiovascular research.

[45]  J. Kawabe,et al.  A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill , 2004, Journal of internal medicine.

[46]  S. Priori,et al.  Genetics of Long QT, Brugada, and Other Channelopathies , 2004 .

[47]  A. George,et al.  Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). , 2003, The Journal of clinical investigation.

[48]  Colleen E Clancy,et al.  Non-Equilibrium Gating in Cardiac Na+ Channels: An Original Mechanism of Arrhythmia , 2003, Circulation.

[49]  G. Breithardt,et al.  Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in DeltaKPQ SCN5A (long QT3) mice. , 2003, Cardiovascular research.

[50]  Lucas J Herfst,et al.  Compound Heterozygosity for Mutations (W156X and R225W) in SCN5A Associated With Severe Cardiac Conduction Disturbances and Degenerative Changes in the Conduction System , 2003, Circulation research.

[51]  S. Priori,et al.  Cardiac Sodium Channel Diseases , 2003, Clinical chemistry and laboratory medicine.

[52]  S. Priori,et al.  Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. , 2002, The Journal of clinical investigation.

[53]  D. Tester,et al.  A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine. , 2002, Cardiovascular research.

[54]  H. Tan,et al.  Pharmacological rescue of mutant ion channels. , 2002, Cardiovascular research.

[55]  Jamie I Vandenberg,et al.  Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[56]  S. Priori,et al.  Natural History of Brugada Syndrome: Insights for Risk Stratification and Management , 2002, Circulation.

[57]  N. Makita,et al.  A mutant cardiac sodium channel with multiple biophysical defects associated with overlapping clinical features of Brugada syndrome and cardiac conduction disease. , 2002, Cardiovascular research.

[58]  P. C. Viswanathan,et al.  Clinical, Genetic, and Biophysical Characterization of SCN5A Mutations Associated With Atrioventricular Conduction Block , 2002, Circulation.

[59]  D. Escande,et al.  Novel SCN5A Mutation Leading Either to Isolated Cardiac Conduction Defect or Brugada Syndrome in a Large French Family , 2001, Circulation.

[60]  Willem Flameng,et al.  Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome , 2001, Nature Medicine.

[61]  S. Priori,et al.  Inherited Brugada and Long QT-3 Syndrome Mutations of a Single Residue of the Cardiac Sodium Channel Confer Distinct Channel and Clinical Phenotypes* , 2001, The Journal of Biological Chemistry.

[62]  J. Balser,et al.  The cardiac sodium channel: gating function and molecular pharmacology. , 2001, Journal of molecular and cellular cardiology.

[63]  P. C. Viswanathan,et al.  A sodium-channel mutation causes isolated cardiac conduction disease , 2001, Nature.

[64]  S. Priori,et al.  Clinical and Genetic Heterogeneity of Right Bundle Branch Block and ST-Segment Elevation Syndrome: A Prospective Evaluation of 52 Families , 2000, Circulation.

[65]  J. Balser,et al.  Enhanced Na(+) channel intermediate inactivation in Brugada syndrome. , 2000, Circulation research.

[66]  A J Moss,et al.  Spectrum of Mutations in Long-QT Syndrome Genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 , 2000, Circulation.

[67]  S. Priori,et al.  The Elusive Link Between LQT3 and Brugada Syndrome: The Role of Flecainide Challenge , 2000, Circulation.

[68]  B. Kerem,et al.  Molecular pharmacology of the sodium channel mutation D1790G linked to the long-QT syndrome. , 2000, Circulation.

[69]  B. Kerem,et al.  Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome? , 2000, Circulation.

[70]  P. Guicheney,et al.  Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes. , 2000, Cardiovascular research.

[71]  M. Chahine,et al.  SCN5A mutation (T1620M) causing Brugada syndrome exhibits different phenotypes when expressed in Xenopus oocytes and mammalian cells , 2000, FEBS letters.

[72]  A. Wilde,et al.  A single Na(+) channel mutation causing both long-QT and Brugada syndromes. , 1999, Circulation research.

[73]  C. Antzelevitch,et al.  Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. , 1999, Circulation.

[74]  A. Wilde,et al.  Cardiac conduction defects associate with mutations in SCN5A , 1999, Nature Genetics.

[75]  D M Roden,et al.  Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel. , 1999, Circulation.

[76]  G. Breithardt,et al.  Genetic basis and molecular mechanism for idiopathic ventricular fibrillation , 1998, Nature.

[77]  J. Balser,et al.  Phenotypic characterization of a novel long-QT syndrome mutation (R1623Q) in the cardiac sodium channel. , 1998, Circulation.

[78]  A. George,et al.  Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[79]  M. Keating,et al.  Mapping a cardiomyopathy locus to chromosome 3p22-p25. , 1996, The Journal of clinical investigation.

[80]  S. Priori,et al.  Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. , 1995, Circulation.

[81]  A. George,et al.  Molecular mechanism for an inherited cardiac arrhythmia , 1995, Nature.

[82]  Arthur J Moss,et al.  SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome , 1995, Cell.

[83]  J. Brugada,et al.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.